Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration of Trastuzumab Deruxtecan and Efficacy in Central Nervous System Metastatic Breast Cancer

NCT07653893 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07653893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07653893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration of Trastuzumab Deruxtecan and Efficacy in Central Nervous System Metastatic Breast Cancer
Lead sponsor
Fudan University
Phase
Observational
Overall status
Recruiting
Start date
June 11, 2025
Completion date
June 30, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, central nervous system (cns) metastases